Exosomes derived from bone marrow mesenchymal stem cells target FOXO1 via miR-183 to reduce apoptosis and oxidative stress in ischemia/reperfused cardiomyocytes, thereby improving cardiac function and preventing myocardial ischemia/reperfusion (MI/R) injury [45]. The gene discussed is FOXO1; the disease is myocardial infarction.